test

Justin Hirsch

@Octagon Capital Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$642.902MTotal holdings41
Assets growth rate1.05%Assets growth rate (2-Q avg)-11.35%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Octagon Capital Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 41 positions.

Assets under management

The assets under management (AUM) of Octagon Capital Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 642.902M in assets, with a quarterly growth rate of 1.05% and a 2-quarter average growth rate of -11.35%. The portfolio is managed by Justin Hirsch, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
EYPTEyepoint Pharmaceuticals Inc
Recent Activity
1.36%
$8.737M
1.094M shares@ $8.0 avg price
PRAXPraxis Precision Medicines I
Recent Activity
Decreased -50%
1.17%
$7.48M
130,000 shares@ $57.54 avg price
MLYSMineralys Therapeutics Inc
Recent Activity
1.14%
$7.266M
600,000 shares@ $12.11 avg price
RGLSRegulus Therapeutics Inc
Recent Activity
1.05%
$6.694M
4.264M shares@ $1.58 avg price
VTYXVentyx Biosciences Inc
Recent Activity
0.82%
$5.213M
2.391M shares@ $2.19 avg price
TNYATenaya Therapeutics Inc
Recent Activity
0.78%
$4.972M
2.576M shares@ $1.93 avg price
CYBNCybin Inc
Recent Activity
New Position
0.68%
$4.353M
489,596 shares@ $8.89 avg price
RPHMReneo Pharmaceuticals Inc
Recent Activity
0.6%
$3.825M
2.25M shares@ $1.7 avg price
UNCYUnicycive Therapeutics Inc
Recent Activity
New Position
0.55%
$3.491M
8.559M shares@ $0.41 avg price
PEPGPepgen Inc
Recent Activity
0.51%
$3.216M
376,117 shares@ $8.55 avg price